CAS: 4591-56-4; Diethyl Pyridine-3,5-Dicarboxylate

相似化合物

499-81-0 5027-65-6 129747-52-0

上下游产品

3,5-Pyridinedicarboxylic acid ethanol 3,5-dibromopyridine carbon monoxide3,5-bis(hydroxymethyl)pyridine 3,5-di(N-β-phenethyl)carbamoylpyridine 5-ethylnicotinate acid 3,5-Lutidine

3,5-二甲基吡啶置于potassium Permanganate,硫酸体系中,用 乙醇,水 作为反应溶剂,化学反应 28.0H,反应生成 3,5-吡啶二甲酸二乙酯
参考文献:将基于双-β-二酮的[m 2 L 2]双核平台自组装为二维配位聚合物†
标题:将基于双-β-二酮的[m 2 L 2]双核平台自组装为二维配位聚合物†
摘要:在其两个β-二酮结构域之间掺入3,5-取代的吡啶环的双-β-二酮配体(1,1'-(吡啶-3,5-二基)双(4,4-二甲基戊烷-1,3-报道了二酮),H 2 L 1)及其与三个二价阳离子(cu 2 +,Zn 2+和pd 2+)的相互作用.在每种情况下均获得类型为[m 2 L 1 2]的带电荷中性双核金属环,并确定了它们的x射线结构.[pd 2 L 1 2]包含两个方形o 4协调的金属中心.锌(II)和铜(II)配合物包含五坐标的o4 N 1-金属中心,相邻的[m 2 L 1 2]金属环中的吡啶氮原子配位形成{[zn 2 L 1 2] N(dmf) N }和{[cu 2 L 1 2] N(dmf) N }.配位聚合物的去溶剂化导致结晶度的损失.
DOI:10.1039/c9Ce00896A

专利信息

专利号:US-2010152208-A1
优先权日:2007-05-23
标 题:Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
发明人：LEGER SERGE; DESCHENES DENIS; FORTIN REJEAN; ISABEL ELISE; POWELL DAVID
权利人:MERCK FROSST CANADA LTD
摘要:Bicyclic heteroaromatic compounds of structural formula I are inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD). The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, such as atherosclerosis; obesity; Type 2 diabetes; insulin resistance; hyperglycemia; Metabolic Syndrome; neurological disease; cancer; and liver steatosis. Formula (I).

专利号:WO-2016120635-A1
优先权日:2015-01-30
标题 :Processes for the preparation of compounds, such as 3-arylbutanals, useful in the synthesis of medetomidine